| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8957259 | The Journal of Heart and Lung Transplantation | 2018 | 36 Pages |
Abstract
An intact intestinal microbiota is required to initiate and sustain the GI toxicity of MMF. MMF treatment causes dynamic changes in the composition of the intestinal microbiota that may be a targetable driver of the GI side-effects of MMF.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kyle L. PhD, Michael R. BS, Sheldon K. BS, Jimena BS, Andrew W. BS, Laurie BS, Xuemei MD, PhD, Karen K. PhD, Paul L. MD, PhD, Kevin P. MD, PhD, Mahesh DVM, PhD, Prasanth K. PhD, Heather J. PhD, Ian A. PhD, Matthew L. PhD, Steven C. MS, MD, Simon A. PhD,